LOS ANGELES, Sept. 20, 2018 /PRNewswire/ -- Open Medicine Foundation (OMF), the premier nonprofit organization investing
OMF is working to put an end to ME/CFS estimated to afflict 20 million globally -- by funding a global research effort to identify diagnostic biomarkers, effective treatments, and ultimately a cure. As part of its efforts to foster open, collaborative research, OMF is funding a three-day scientific working group meeting in which over 50 world-class scientists with diverse expertise will share their latest results and chart a path forward, followed by the Community Symposium, at which highlights of these results will be shared with the public.
Linda Tannenbaum, OMF founder and CEO/President, will welcome guests at this year's symposium and highlight the importance of open collaboration to fast track solutions. The keynote address will be delivered by Oystein Fluge, MD, PhD, of Norway. Additional scientists speaking include the Symposium Chair Ronald Davis, PhD; the Symposium Moderator Raeka Aiyar, PhD; Maureen Hanson, PhD; Jonas Bergquist, MD, PhD; Wenzhong Xiao, PhD; Alain Moreau, PhD; Ronald Tompkins, MD, ScD; Jared Younger, PhD; Michael Sikora, graduate student; and Rob Phair, PhD, who will speak about the new metabolic trap hypothesis.
OMF currently funds ME/CFS Collaborative Research Centers at Stanford and Harvard. Scientists from both centers will present their research at this year's symposium.
To register for the symposium Livestream, click here.
For interviews with Linda Tannenbaum and Dr. Ron Davis, please contact Publicist Sylvia Paull (firstname.lastname@example.org 510-388-8932) or email@example.com for more information.
Founded as a nonprofit in 2012, OMF has raised over $15 million to fund research and increase public awareness with the patient and medical communities. OMF's funded research is overseen by a renowned Scientific Advisory Board, including three Nobel laureates and six members of the National Academy of Sciences, directed by Ronald W. Davis, PhD, Director of the Stanford Genome Technology Center. www.omf.ngo
View original content:http://www.prnewswire.com/news-releases/open-medicine-foundation-sponsors-second-annual-community-symposium-on-the-molecular-basis-of-mecfs-at-stanford-university-300716381.html
SOURCE Open Medicine Foundation
Subscribe to our Free Newsletters!
Oxidative stress is a form of injury to body tissues due to increase in free radicals. If the ...
Graviola's health benefits range from curing headaches to fighting cancer. Read on to know more ...
Gene therapy is a specialized procedure where genetic material is introduced into the cells of a ...View All